A Bengali-Hindi-Telugu parallel corpus for enhanced literary machine translation
Data in Brief · 2026-06 · 66 · 112775
DOI: 10.1016/j.dib.2026.112775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Data in Brief, 2026-06. Verfasst von Sudeshna Sani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science and Engineering, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Electronics and Information technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer Science and Engineering, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India.
- Department of Computer Science and Engineering, Faculty of Science and Technology (ICFAI Tech.), ICFAI Foundation for Higher Education (IFHE), Hyderabad, India.
- School of Business, Woxsen University, Hyderabad, Telangana, India.
- School of Technology, Woxsen University, Hyderabad, Telangana, India.
Förderung
- Ministry of Electronics and Information technology
Zitieren
APA
Sani, S., Gangashetty, S. V., K, S., Nandi, A., Priya, A., Kumar, V., & Dubey, A. K. (2026). A Bengali-Hindi-Telugu parallel corpus for enhanced literary machine translation. Data in Brief, 66, 112775. https://doi.org/10.1016/j.dib.2026.112775
Vancouver
Sani S, Gangashetty SV, K S, Nandi A, Priya A, Kumar V, et al. A Bengali-Hindi-Telugu parallel corpus for enhanced literary machine translation. Data in Brief. 2026;66:112775. doi:10.1016/j.dib.2026.112775
BibTeX
@article{Sani2026,
author = {Sani, Sudeshna and Gangashetty, Suryakanth V and K, Samudravijaya and Nandi, Anik and Priya, Aruna and Kumar, Vineeth and Dubey, Akhilesh Kumar},
title = {A Bengali-Hindi-Telugu parallel corpus for enhanced literary machine translation},
journal = {Data in Brief},
year = {2026},
volume = {66},
pages = {112775},
doi = {10.1016/j.dib.2026.112775}
}
EUVIMED